Commercial Transformation · Life Sciences

Fragmented data.
Disconnected decisions.
Untapped value.

We help growth-stage life sciences companies build commercial infrastructure, execute GTM strategy, and convert scientific complexity into revenue.

We work where scientific complexity, fragmented systems, and commercial growth intersect.

Map Your Opportunity View Our Approach

The status quo: disconnected environments

Instrument
Data
LIMS /
ELN
Clinical
Ops
CRM /
Sales
Supply
Chain
Sequencing
Pipelines
Regulatory
Docs
Finance /
ERP
vs. the opportunity
⬡
Unified Commercial Intelligence Layer
Single source of truth connecting process, data, and GTM execution
20+Yrs Experience
$367MRevenue Managed
26Global Pharma Accts
Who We Work With

Built for builders
in life sciences.

🚀
Growth-stage life sciences platforms
Series A–C companies building their first commercial function or scaling beyond founder-led sales.
💻
Scientific informatics & SaaS companies
LIMS, ELN, data catalog, and workflow platforms entering regulated pharma and clinical markets.
🧬
Biopharma & genomics innovators
Pre-commercial and early-commercial platforms in rare disease, CGT, precision medicine, and diagnostics.
🏗
Founders & commercial leaders building GTM infrastructure
CEOs and CCOs who need a senior commercial partner — without the overhead of a full-time hire.
Experience spanning
Thermo Fisher Scientific Takara Bio / Clontech L7 Informatics Codebreaker Labs
The Core Challenge

Legacy environments are
costing you more than you think

Healthcare, biotech, and pharma share a structural problem: disconnected instruments, fragmented workflows, and siloed data force critical decisions in the dark. The result isn't just inefficiency — it's compounding commercial risk at every handoff.

🔭
No Visibility Across the Value Chain
No real-time view of where specimens, treatments, or commercial opportunities stand. Leaders navigate by assumption.
🗂
Missing Metadata & Data Context
Data exists — but without provenance, lineage, or searchability. No "Google for your scientific and commercial data."
⚙️
No Automation Architecture
Manual handoffs and spreadsheet tracking drive excess cost, compliance risk, and velocity loss on time-critical workflows.
🔗
Silos That Compound Across Enterprises
Fragmentation doesn't stop at division lines — it multiplies across CRO, CDMO, and clinical site partners.
📊
No Global Reporting Layer
P&L leaders can't tie initiative-level activity to financial impact. The transformation at the bench never surfaces to the boardroom.
🎯
GTM Strategy Without Signal
Commercial strategies built on lagging indicators miss the window. Good decisions require a real-time data foundation.

Precision medicine workflow — without a unified layer

Wet Lab → Manual log → Email handoff
Sequencing → Separate LIMS → No linkage
Analysis → Spreadsheet → PDF report
Diagnosis → Siloed EMR → No provenance
Treatment → Manual infusion log → No audit trail
Where value leaks
Manual handoffs Spreadsheet tracking No chain of custody Spec fragmentation Compliance gaps No audit trail Siloed reporting
How We Help

Four pillars of commercial transformation

We work where scientific complexity, fragmented systems, and commercial growth intersect — bringing 20+ years of enterprise life sciences GTM experience to the challenges that keep founders and commercial leaders up at night.

01
🔬
Commercial Architecture
Design and build the GTM infrastructure — CRM, territory model, account segmentation — that connects your scientific value to buyer decisions at scale.
02
🤝
Strategic Partnerships & BD
Identify, structure, and close partnerships that compound platform value — from Pioneer Programs to strategic alliances that create durable pipeline.
03
📡
Data-Driven GTM Strategy
Translate scientific differentiation into a go-to-market thesis powered by market intelligence, competitive landscape analysis, and account-level signal.
04
📈
Revenue Acceleration
From second-source entry to sole-source conversion — structure commercial sequences that lock in account value and build the compounding engine.
Engagement Models

Choose how we work together

Three structured ways to engage — sized for the stage you're at and the outcome you need.

Fractional
Fractional VP / Director
Ongoing senior commercial leadership without a full-time hire. Ideal for pre-commercial and Series A–B companies.
  • Commercial strategy ownership — targets, pipeline, and GTM execution
  • CRM build-out and sales process design (HubSpot, Salesforce)
  • Territory model, ICP definition, and account segmentation
  • BD outreach campaigns and partner development
  • Weekly leadership team participation
Discuss Your Needs
Most Popular
90-Day Commercial Sprint
A focused engagement with a defined outcome. Diagnose, design, and launch — in one quarter.
  • Commercial landscape analysis and competitive positioning
  • GTM thesis and account prioritization framework
  • Pioneer or key account outreach program (full execution)
  • Partner pipeline with executed LOIs or signed agreements
  • Playbook handoff your team can own and scale
Start the Sprint
Project
Strategic Advisory Project
A discrete deliverable for a specific strategic decision. Fast, focused, and ready to present to your board.
  • M&A target identification and commercial diligence
  • Market entry analysis for new geographies or segments
  • Competitive landscape deep-dives (CGT, genomics, medtech)
  • Key account strategy for a single named account
  • Two-week turnaround on most deliverables
Scope a Project
How It Works

From diagnostic to sustained impact

Every engagement moves through a disciplined five-step sequence — connecting strategy to execution and execution to measurable value.

🔍
1
Diagnose
Map the current state — data environment, commercial infrastructure, competitive position, and value leakage points.
🗺
2
Design
Build the commercial thesis, prioritize initiatives, and set outcome-driven targets with clear financial traceability.
✅
3
Validate
Pressure-test the strategy — pilot outreach, partner discovery, and early-stage market signal collection.
🚀
4
Launch & Realize
Execute at speed — BD campaigns, key account activation, partnership closings, and pipeline development.
♻️
5
Embed & Scale
Build the playbook and capability your team owns — processes, tooling, and habits that sustain impact after we're done.
Why Stacks Advisory

What makes this different

Most advisors bring strategy or domain expertise. Rarely both. And almost never with the operational depth to execute alongside you.

🔬
Built at the bench, proven in enterprise sales
A BA in molecular biology plus 20+ years of commercial execution means we speak both languages — scientific and commercial — without translation loss.
🔁
Experience across tools, SaaS, and biopharma
Most advisors know one sector. We've operated across life science tools, genomics platforms, biotech SaaS, and biopharma — giving us pattern recognition that generalists don't have.
⚙️
Focus on execution, not just strategy
We don't hand off decks. Engagements end with working CRM architecture, executed outreach, signed LOIs, or a playbook your team can run — not a recommendation.
🌱
Designed for pre-commercial and growth-stage companies
We're not built for Fortune 500 transformation programs. We're built for companies where the first commercial hire, first partnership, or first key account close actually changes the trajectory.
Track Record

Experience that shows up in context

Twenty years of enterprise life sciences commercial work — from supporting Thermo Fisher's $13.6B Life Technologies integration to joining L7 Informatics as the first commercial hire.

$367M Revenue base managed across 26 global pharma accounts during the Thermo Fisher integration
$13.6B Acquisition scale of the Life Technologies integration — one of the largest in life sciences tools history
25+ Enterprise logos contributed to across biopharma and academic medical centers at L7 Informatics
20+ Years across tools, genomics, biopharma SaaS, and medtech commercial roles
Biopharma SaaS
Building commercial infrastructure from the ground up
Joined L7 Informatics as employee #18 and first commercial hire. Helped design and build the initial GTM infrastructure — CRM, territory model, account segmentation, and partner program — contributing to growth across biopharma and academic medical center accounts.
25+ enterprise logos developed · global sales team established
Enterprise Key Accounts
Supporting key account continuity through a $13.6B integration
Led key account strategy during Thermo Fisher's Life Technologies integration — supporting commercial execution across 26 global pharma accounts in 14 countries as two organizations merged into a unified go-to-market structure.
Contributed to integration-period continuity across a $367M revenue base
Rare Disease Genomics
Early partner development for a pre-commercial genomics platform
Contributing to BD and partnerships at Codebreaker Labs — helping structure a Pioneer Program, supporting outreach to institutional partners, and contributing to early LOI conversations with Arpeggio Bio and Sant Joan de Déu Barcelona.
2 LOIs in progress · US + EMEA pipeline developing
Cell & Gene Therapy
CGT market mapping and biopharma re-engagement motion
Built pipeline and re-engagement motion across major biopharma targets in CAR-T, GLP-1, and rare disease — including account mapping, competitive landscape framing, and outreach sequencing across AstraZeneca, AbbVie, Eli Lilly, and Kyverna Therapeutics.
Active re-engagement conversations underway · multi-program pipeline developing
Domain Expertise

Built at the bench.
Proven in the market.

A foundation in molecular biology paired with 20+ years of enterprise commercial execution means we understand your science — and we know exactly how to sell it.

🧬
Genomics & Sequencing
NGS platforms, bioinformatics workflows, rare disease genomics, causal variant analysis, and precision medicine data infrastructure.
💊
Biopharma & Cell / Gene Therapy
CAR-T manufacturing workflows, CGT CDMO/CRO testing ecosystems, regulatory strategy, and CGT CAGR modeling with FDA/HHS overlay.
🔬
Life Science Tools & Instruments
Enterprise accounts at Thermo Fisher, Takara Bio/Clontech, and BD — deep knowledge of reagent, instrument, and consumables commercial motion.
💻
Scientific Informatics & Biotech SaaS
LIMS, ELN, data catalog, and scientific process management platforms — and the commercial architecture that drives SaaS adoption in regulated environments.
Jon Stacks
Founder · Senior Commercial Advisor
20+ years leading enterprise commercial strategy across life science tools, genomics, and biopharma SaaS. Former Sr. Manager of Corporate & Strategic Accounts at Thermo Fisher Scientific, Western Regional Manager at Takara Bio/Clontech, and Director of Sales & Strategic Accounts at L7 Informatics (employee #18, first sales hire).

Available for fractional VP/Director engagements in BD, GTM strategy, strategic accounts, and commercial build-outs for pre-commercial and growth-stage life sciences companies.

BA in Molecular, Cellular, and Developmental Biology · University of Colorado Boulder · Based in Denver, CO.
Thermo Fisher Takara Bio L7 Informatics Codebreaker Labs Denver, CO

Ready to turn your data environment
into a commercial advantage?

We work where scientific complexity, fragmented systems, and commercial growth intersect.

Whether you're building a commercial function from zero, navigating a complex key account, or designing a partnership program — start with a 30-minute commercial diagnostic. No pitch deck. No obligation.

Schedule a 30-Minute Commercial Diagnostic View Full Capabilities